Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The First Confirmed Outbreak of Recombinant Myxomatosis Virus in the Brown Hare (Lepus europaeus P.) Population in Hungary.

Transboundary and emerging diseases·2026
Same author

Lazy Sundays: role of day of the week and reactivity on objectively measured physical activity in older people.

European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity·2019
Same author

Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients.

BMC cancer·2019
Same author

Evaluation of left and right ventricular systolic and diastolic electromechanical synchrony in older people: a population-based observational study.

Physiological research·2017
Same author

[Sports cardiology : Overview of relevant clinical topics].

Herz·2017
Same author

The role of sex, adiposity, and gonadectomy in the regulation of irisin secretion.

Endocrine·2016

Related Experiment Video

Updated: Jun 14, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

[Electrical cardioversion for atrial fibrillation].

R Laszlo1, S Laszlo, H Graze

  • 1Abteilung für Kardiologie und Kreislauferkrankungen, Klinikum der Eberhard-Karls-Universität Tübingen, Tübingen. roman.laszlo@gmx.de

Deutsche Medizinische Wochenschrift (1946)
|April 8, 2010
PubMed
Summary

Electrical cardioversion effectively restores sinus rhythm in atrial fibrillation (AF). Immediate cardioversion is safe for AF under 48 hours, while longer durations require anticoagulation or echocardiography to prevent thrombotic events.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Related Experiment Videos

Last Updated: Jun 14, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Area of Science:

  • Cardiology
  • Electrophysiology

Context:

  • Atrial fibrillation (AF) is a common arrhythmia requiring rhythm control.
  • Electrical cardioversion is a primary treatment for AF.
  • Management strategies are crucial to optimize cardioversion success and minimize risks.

Purpose:

  • To review the management of patients undergoing electrical cardioversion for atrial fibrillation.
  • To outline strategies for pre- and post-cardioversion care.
  • To discuss factors influencing cardioversion success and complication rates.

Summary:

  • Immediate cardioversion is suitable for AF <48 hours unless high thrombotic risk exists.
  • For AF >48 hours, anticoagulation (≥3 weeks) or transesophageal echocardiography is necessary to exclude thrombi.
  • Biphasic shocks improve success rates.
  • Amiodarone and subsequent antiarrhythmic therapy can prevent recurrence.
  • Post-cardioversion anticoagulation duration depends on individual risk (e.g., CHADS(2) score) and AF duration.

Impact:

  • Optimized patient selection and management protocols enhance cardioversion efficacy.
  • Risk stratification and appropriate anticoagulation reduce the incidence of thromboembolic complications.
  • Understanding factors affecting success rates allows for personalized treatment approaches.